-
CR UK makes further cuts in COVID's wake
pharmatimes
December 09, 2020
Cancer Research UK has announced further catastrophic cuts in the wake of the coronavirus pandemic, slashing ￡45 million from its research budget, leaving dozens of potential life-saving projects and hundreds of world-class scientists unfunded.
-
CR UK pairs with Abcam
pharmatimes
July 09, 2020
Cancer Research UK (CR UK) has paired with Abcam to develop and commercialise novel custom antibodies to support the acceleration of cancer research.
-
Research charities warn of funding cuts in coronavirus wake
pharmatimes
June 24, 2020
Charities including Cancer Research UK (CR UK) and the British Heart Foundation are warning that research funding will take a substantial hit in the wake of COVID-19 and that this will likely have significant consequences on survival.
-
Cancer Research and AstraZeneca launch genomics centre
pharmatimes
December 11, 2018
Cancer Research UK and AstraZeneca have announced that they are opening a new centre in Cambridge, UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.
-
CR UK invests ￡14m in London cancer biotherapeutics hub
pharmatimes
September 20, 2018
Cancer Research UK is investing some ￡14 million into transforming the city of London into a “world-leading hub for cancer biotherapeutics”.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
